This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The management of chronic paronychia involves:

  • dipstix urine to exclude covert diabetes mellitus
  • if history is suggestive, swab for vaginal candidosis
  • taking swabs and scrapings for exact diagnosis
  • advise the patient to avoid exposure to contact irritants or getting their hands wet
  • emollient lotions – lubricating the nascent cuticle and the hands is usually helpful
  • topical anticandidal preparation such as:
    • miconazole cream packed into the nail fold
    • clotrimazole solution applied to nail fold
  • the first line of treatment in patients with chronic paronychia should be topical steroids
  • a combination of topical steroids and antifungal agents can be used in simple chronic paronychia as an alternative therapy
  • systemic corticosteroids – can be used for a limited period of time in severe paronychia involving several fingernails
  • systemic antifungals – can be sued in a trial basis for patients who do not respond to topical treatment and other preventive measures (1)
  • if pus is present it can often be released by simply lifting the nailfold from the nail; otherwise, it must be incised. Sometimes a portion of the nail needs to removed as detailed for acute paronychia.

 

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.